Management Forum courses now available at IPI Academy - visit IPI for an updated experience and a broader selection of courses and subjects

Injectable Drug Delivery Training Course

Advances in technology for pens, auto-injectors, large volume pumps, patch pumps, needle-free, pre-filled syringes and other parenteral methods.


Course overview

Newly Updated Programme for 2020 !

Injectable drug delivery is considered to be one of the most effective routes of administration due to the speed and effectiveness of delivery to the target, and recent developments have improved the patient experience. The global injectable drug delivery market continues to grow and technology is advancing. This, coupled with the ever-changing regulatory requirements, means that it is imperative for companies to stay abreast of the latest developments and challenges within the industry in order to remain compliant, as well as gaining a competitive edge.

This seminar has been designed to provide all those working in the industry with the latest information on the next generation of injectable drugs and devices and an update on recent trends, technologies and applications. It will also be a great opportunity to meet industry leaders, as well as like-minded professionals, and share common experience and best practice.

Attending this two-day seminar, presented by experts in the field, will:

  • Give you a valuable update on the advances in injection technology and drug delivery
  • Present you with up-to-date information on the latest market trends and opportunities for your organisation
  • Provide you with an opportunity to develop significant business partnerships

Previous Exhibitors Include:

3PInnovation logo

Harro Hofliger logo

Owen Mumford logo

ODD logo

Advanex logo

Exhibition opportunities are available. Please contact Customer Services on +44 (0)20 7749 4730
or contact us through our contact form.

Who should attend

This is a key seminar for all those working in the parenteral delivery area, including:

  • Device development managers
  • Senior project managers
  • Engineering directors
  • Formulation specialists
  • Principal scientists
  • Research and development associates
  • Business development managers
  • Market development directors
  • Associate directors of regulatory affairs
  • Heads of strategic product management
  • Medical device quality managers
  • Pre-sales and sales managers
  • Project managers
  • Biomedical engineers
  • Device technology managers
  • Device engineers

Programme day one

Devices, technology and latest trends

Latest developments for injectable drug delivery solutions

  • Market overview and trends
  • How can a science-driven CDMO help to accelerate developments for biologics? • Case study
    Dr Thomas Schoenknecht

Recent advances in large-volume injection

  • Large-volume autoinjectors
  • Patch injectors
  • Latest usability insights into autoinjector and patch injector systems
    Ian Thompson

Discussion session

Developments in technology with injectables – digitalisation and smart technology

  • ‘Internet of me’ – connected drug delivery advances
  • Sustainable patient engagement for better outcomes
  • Market forces and business drivers
    Neil Williams

Digital design in development of injectable systems

  • Hardware and software solutions
  • Integration into the connected ecosystem
  • Device management trends
    Markus Bauss

Discussion session

Case study: Connected needle-free technology

  • Adherence to treatment in injectable therapies for chronic disease is very low
  • Opportunities with a new form of drug delivery that is needle-free
  • Transforming the perception and approachability of therapies based on injectable biologics
  • Next-gen needle-free drug delivery platform that is computer-controlled • Supporting patient needs
  • Clinical and market studies – results and findings
    Patrick Anquetil

Patient considerations and design processes

Assessing injection site pain

  • Understanding how to measure pain and tolerability during injection and how to interpret the results
  • Summary of recent clinical investigations
  • Impact on the design and selection of drug delivery devices
    Chris Muenzer

Discussion session

Betwixt and between – managing the interface between PFS and autoinjector

  • Understanding the physical interface between PFS and autoinjector
  • A framework for ensuring compatibility across the interface
  • Working together in harmony – the organisational interface between pharma, syringe manufacturer and device developer
    Dr Jeffrey Philippson

Interactive panel discussion: Next generation innovations in drug delivery
Moderator: Dr Gregory Berman
Panellists: Ian Thompson, Neil Williams, Markus Bauss, Dr Thomas Schoenknecht

Drinks reception

Programme day two

Regulatory update and human factors

The EU regulatory framework for injectable delivery systems

  • Deciding on your regulatory strategy
  • Implications of the Medical Device Regulation (EU) 2017/74 and Article 117 for drug delivery systems
  • Classification – the importance of getting it right from the start
  • Combination products – drug/device, device/drug?
  • Essential considerations for injectable medicinal products
  • Brexit implications
    Dr David Jefferys

Human factors validation – when is usability testing not required?

  • Overview of regulatory guidelines covering human factors for combination products • Considerations for determining if a study will be required
  • Utilising comparative analyses
  • Approaches to compiling supporting evidence
    Lee Wood

Discussion session

Sustainability – its impact on self-care drug delivery

  • The circular economy
  • Sustainability and the pharma industry
    Gregor Anderson

Packaging and quality

Extractables and leachables (E&L) in injectable drug products

  • The ongoing evolution of thresholds for control of E&L in drug products
    Raphael Nudelman

Discussion session

Pre-filled syringes in a nutshell

  • The components
  • The building blocks
  • Potential options
  • Lure-tip syringes, dual-chamber pre-filled syringes and staked-in needles
  • How everything comes together
    Dr Andreas Rothmund

The relationship between the ICH guidelines for impurities and E&L thresholds

  • ICH guidelines for impurities and non-mutagenic impurities
  • Principles from the ICH guidelines for impurities that can be used for the risk assessment of E&L in drug products
    Raphael Nudelman

Interactive panel discussion: The future with smart injection devices
Moderator: Dr Gregory Berman
Panellists: Ian Thompson and Dr Thomas Schoenknecht

Chair’s closing remarks

Book now

Book now

We do not currently have dates confirmed for this course; please contact us to be informed when it is scheduled; or to discuss running this course on an in-house basis for your staff.

Continuing professional development

This course qualifies for 12 hours for your CPD records.
More about CPD

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • Actavis
  • BD Medical - Pharmaceutical Systems
  • Beaufour Ipsen Industrie
  • Becton Dickinson
  • Biogen Idec Ltd
  • Celanese Emulsions BV
  • DSTL
  • Eli Lilly and Company
  • Eveon SA
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche Ltd
  • Genentech
  • Genentech Inc
  • Grunenthal GmbH
  • GSK
  • Letcat AB
  • Medimmune
  • Merck
  • Nemera La Verpilliere
  • NNE Pharmaplan
  • Oval Medical Technologies Ltd
  • PA Consulting Group
  • Portal Instruments
  • Rothschild & Compagnie Gestion
  • RPC Formatec GmbH
  • Takeda Pharma A/S
  • Teva Pharmaceutical Industry Limited
  • Texchem-Pack (M) Bhd
  • Vetter Pharma International GmbH
  • West Pharmaceutical Services Inc.

Generally very good. We were well looked after. Venue excellent, management forum very professional. Needs more than just device suppliers in attendance.

Victoria Morgan, Director Segment Marketing, West Pharmaceutical Services, Mar 19

Very good and useful. Excellent.

Gajane Zurawska, Global Marketing Director, HTL-STREFA S.A. , Mar 19

Topics well selected. Good speakers and broadly based.

Stefan Gaul, Head of Strategic Product Management, Haselmeier AG, Mar 19

Good conference. Will most likely come again.

Thomas Mayer, Intl. Key Account Manager, Sonceboz SA, Mar 17

Very good

Roland Marshall, Account Manager, Owen Mumford Ltd, Mar 17

Well worth the time

David Haase, Senior Manager Device Development, Genentech, Mar 17